Yingqi Hua

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Sentinel Lymph Node

Replacement Therapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Cancer biology & medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yafei Jiang, Jinzeng Wang, Mengxiong Sun, Dongqing Zuo, Hongsheng Wang, Jiakang Shen, Wenyan Jiang, Haoran Mu, Xiaojun Ma, Fei Yin, Jun Lin, Chongren Wang, Shuting Yu, Lu Jiang, Gang Lv, Feng Liu, Linghang Xue, Kai Tian, Gangyang Wang, Zifei Zhou, Yu Lv, Zhuoying Wang, Tao Zhang, Jing Xu, Liu Yang, Kewen Zhao, Wei Sun, Yujie Tang, Zhengdong Cai, Sheng-Yue Wang, Yingqi Hua
Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment. Nature communications 13 (1) (2022)
Haoran Mu, Dongqing Zuo, Jie Chen, Zhigang Liu, Zhuo Wang, Liu Yang, Qihui Shi, Yingqi Hua
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis. Cancer biology & medicine 19 (9) (2022)
Yan Zhou, Qing-Cheng Yang, Yang Dong, Tong Ji, Bing Zhang, Cheng Yang, Shuier Zheng, Lina Tang, Chenliang Zhou, Guowei Qian, Yujing Huang, Wenxi Yu, Hongtao Li, Yonggang Wang, Aina He, Zan Shen, Weibin Zhang, Yingqi Hua, Hongyu Bai, Jiayi Zhao, Benjamin X Li, Xiangrong Dai, Jianjun Zhang, Hai-Yan Hu, Yang Yao
First-in-maintenance therapy for localized high-grade osteosarcoma: an open-label phase I/II trial of the anti-PD-L1 antibody ZKAB001. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)